HEALTH● LOWJul 24 · Jul 24, 2026, 9:40 PM
CEPI begins first human trial of Bundibugyo Ebola vaccine
Premium Times
The Phase I clinical trial, known as BD-Ebov, will evaluate the safety of the experimental vaccine and its ability to stimulate immune responses in healthy adult volunteers. The post CEPI begins first human trial of Bundibugyo Ebola vaccine appeared first on Premium Times Nigeria.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH43m agoLassa fever: NCDC identifies preparedness gaps, unveils readiness plan ahead of peak seasonPremium TimesHEALTH1h agoExperimental AstraZeneca Drug Reduces COPD Flare-Ups in Late-Stage TrialsHuman ProgressHEALTH2h agoPublic Health Under Pressure : Brian Castrucci , DrPh , on Cyclospora , Trust , and the Cost of Underinvestmentinfectioncontroltoday.com · United StatesHEALTH2h agoFamily Lawyer Describes Irreversible Brain Damage from Heat Stroke as Two Investigations Open into an ASU Workoutmedicaldaily.com · United States